We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 1,401 results

  1. Bladder EpiCheck urine test in the follow-up of NMIBC: a cost analysis

    Purpose

    In the Netherlands yearly more than 5000 patients are diagnosed with non-muscle invasive bladder cancer (NMIBC). With a specificity of 88.0%...

    Marlène Charlotte Henrique Hekman, Stan Robert Willem Wijn, ... Johannes Alfred Witjes in World Journal of Urology
    Article 19 December 2022

  2. Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review

    Background

    Bladder cancer detection and follow-up is based on cystoscopy and/or cytology, but it remains imperfect and invasive. Current research...

    Yanish Soorojebally, Yann Neuzillet, ... François Audenet in World Journal of Urology
    Article 02 January 2023

  3. NMIBC: BCG wirkt altersunabhängig

    Robert Bublak in Uro-News
    Article 10 October 2023

  4. Investigation of Atypical Cell Parameter in the Surveillance of Patients with NMIBC; Initial Outcomes of a Single Center Prospective Study

    Objective: To investigate how well the Sysmex automated urine-analyzer’s atypical-cell parameter can predict oncological outcomes when compared to...

    Murat Can Karaburun, Mehmet Fatih Özkaya, ... Evren Süer in Journal of Medical Systems
    Article 28 March 2023

  5. Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)

    Objectives

    The treatments for high-grade non-muscle invasive bladder cancer (NMIBC) vary between bladder preserving intravesical approaches and...

    Owen Alan Edwards Cooper, Ola Ghatnekar, ... Jørn Skibsted Jakobsen in PharmacoEconomics - Open
    Article Open access 03 February 2023

  6. BCG-naives Hochrisiko-NMIBC

    Heidrun Rexer, Arnulf Stenzl, Carsten Henning Ohlmann in Uro-News
    Article 05 June 2024

  7. NMIBC ohne Zystektomie-Option

    Heidrun Rexer, Martin Bögemann, Carsten Henning Ohlmann in Uro-News
    Article 08 November 2023

  8. Nicht-muskelinvasives Harnblasenkarzinom (NMIBC) – Rezidivprophylaxe bei geringem und intermediärem Risiko

    Background

    Low- and intermediate-risk non-muscle invasive bladder cancer (NMIBC) is characterized by a relatively high risk of recurrence and adjuvant...

    Georgios Gakis in Der Urologe
    Article 15 October 2021

  9. Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?

    Purpose

    Radical cystectomy (RC) is the standard treatment for high-risk non muscle-invasive bladder cancer (NMIBC) failing first BCG treatment. A...

    Gian Maria Busetto, Marco Finati, ... Luigi Cormio in World Journal of Urology
    Article Open access 27 March 2023

  10. Sekundärprävention des nichtmuskelinvasiven Blasenkarzinoms (NMIBC)

    H. Rexer, M. Kramer, A. Merseburger in Forum
    Article 05 September 2022

  11. Interruption of BCG Therapy for NMIBC During COVID-19 Crisis, Dilemma in Its Continuation: a Review of Available Evidence and Suggested Management Strategies

    The COVID-19 disease, caused by SARS-CoV-2 virus, has been one of the worst pandemics ever to hit the human mankind. Undoubtedly the start of the...

    Jyoti Mohan Tosh, Vikas Kumar Panwar, ... Arup Kumar Mandal in Indian Journal of Surgical Oncology
    Article 03 April 2023

  12. Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)

    Background

    Intravesical bacillus Calmette-Guérin (BCG) fails in a considerable proportion of non-muscle invasive bladder cancer (NMIBC) patients...

    Edward I. Broughton, Kyna M. Gooden, ... Gavin Taylor-Stokes in BMC Urology
    Article Open access 26 February 2022

  14. Intravesical ICIs to reduce toxicity in NMIBC

    Maria Chiara Masone in Nature Reviews Urology
    Article 31 October 2022

  16. Bladder EpiCheck for NMIBC

    Tim Thomas in Nature Reviews Urology
    Article 13 January 2022

  18. NMIBC: Test auf DNA-Methylierung statt Zytologie?

    Robert Bublak in Uro-News
    Article 08 February 2022

  19. NMIBC risk factors in patients treated with BCG

    Maria Chiara Masone in Nature Reviews Urology
    Article 14 January 2022
Did you find what you were looking for? Share feedback.